Behind the veneer of accessibility lies a critical bottleneck in clinical trial readiness, especially pronounced in trials ...

AI startup ByteBrain is transforming clinical trials with agent-based optimization, cutting costs, boosting efficiency, and ...

Onsite, the leading provider of point-of-need ophthalmic services for clinical trials, announces the deployment of its latest ...

The new FDA commissioner and Center for Biologics Evaluation and Research (CBER) director laid out their vision for the ...

The programme aims to address barriers for CROs, enabling them to reduce clinical trial timelines by at least 50%.

While all groups have demonstrated an inspiring level of dedication and passion, I have always been moved by patients’ ...

Spain’s SpliceBio will use $135 million from a series B round backed by Sanofi and Roche to advance its lead gene editing ...

Medable Inc., a leading provider of clinical development technology, today unveiled its new Partner Program, designed to empower contract research organizations (CROs) and other partners with ...

Neuroscience technology company Brooklyn Health is using artificial intelligence to target a fundamental problem in neurology ...

Metallic nanoparticles injected into the retina partly restored vision in blind mice and could work as a treatment for ...

The TEASE-1 trial reveals gildeuretinol's potential to reduce vision loss in Stargardt disease, offering hope for future ...

The company has received FDA Breakthrough Device Designation for its Blindsight vision restoration system and a speech ...